Association of increased QT dispersion with coronary atherosclerosis in patients with aortic stenosis

Related Experiment Videos

C H Tsai1, S F Su, T M Lee

  • 1Department of Surgery, Center for Cardiovascular Research, College of Medicine, National Taiwan University Hospital, Taipei.

Insights

Electrocardiographic QT dispersion, a measure of heart rhythm variability, is a significant predictor of coronary artery disease in patients with aortic stenosis. Wider QT dispersion indicates a higher likelihood of significant coronary artery disease.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Clinical Electrophysiology

Background:

  • Aortic stenosis often coexists with coronary artery disease.
  • Predicting coronary atherosclerosis in aortic stenosis patients is clinically important.

Purpose of the Study:

  • To investigate the correlation between electrocardiographic QT dispersion and coronary atherosclerosis in patients with aortic stenosis.
  • To identify QT dispersion as a potential non-invasive marker for significant coronary artery disease.

Main Methods:

  • A comparative study involving 78 patients (39 with significant coronary lesions, 39 without) undergoing aortic valve replacement.
  • Electrocardiograms were used to measure QT dispersion, defined as the difference between maximal and minimal QT intervals across 12 leads.
  • Coronary artery stenosis was assessed using digital angiography.

Main Results:

  • QTc dispersion was an independent predictor of coronary artery disease in patients with aortic stenosis (odds ratio=1.255, P=0.01).
  • A QTc dispersion of ≥70 ms showed 72% sensitivity and 79% specificity for detecting significant coronary artery disease.
  • Positive accuracy for significant coronary artery disease with QTc dispersion ≥70 ms was 78%.

Conclusions:

  • Electrocardiographic QTc dispersion provides valuable clinical information in patients with aortic stenosis.
  • A wide QTc dispersion is associated with a high incidence of coronary artery disease, suggesting its utility as a predictive marker.
  • Further large-scale trials are warranted to confirm these findings.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...